Literature DB >> 6634553

Altered glycosylation and sialylation of serum proteins and lipid bound sialic acids in chronic renal failure.

B K Kishore, F Gejyo, M Arakawa.   

Abstract

Abnormalities in the metabolism of carbohydrates, lipids and proteins are well documented in chronic renal failure (CRF). We have studied the extent of glycosylation and sialylation of serum proteins and also the levels of lipid-bound sialic acids in nondiabetic patients with CRF maintained on haemodialysis. The total neutral sugar content (TNS) and the non-enzymatic glycosylation (NEG) of serum proteins, the protein-bound sialic acids (PSA) and the lipid-bound sialic acids (LSA) were found to be significantly elevated in the patients as compared to a group of healthy controls. A single dialysis therapy produced some alterations in these measurements. The TNS correlated significantly with the NEG and also with the PSA. No correlation existed between total lipids. None of these measurements, however, correlated with the serum creatinine values. The established as well as putative pathophysiological consequences of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6634553      PMCID: PMC2417616          DOI: 10.1136/pgmj.59.695.551

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  16 in total

1.  SERUM PYRUVATE AND LACTATE IN UREMIA.

Authors:  R E GALLOWAY; J M MORGAN
Journal:  Metabolism       Date:  1964-09       Impact factor: 8.694

Review 2.  The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins.

Authors:  G Ashwell; A G Morell
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1974

3.  Abnormal preponderance of sialylated apolipoprotein CIII in triglyceride rich lipoproteins in type V hyperlipoproteinemia.

Authors:  M L Kashyap; B A Hynd; K Robinson; P S Gartside
Journal:  Metabolism       Date:  1981-02       Impact factor: 8.694

4.  Improved method to determine lipid bound sialic acid in plasma or serum.

Authors:  N Katopodis; C C Stock
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1980-10

5.  Nonenzymatic glucosylation of serum proteins in diabetes mellitus.

Authors:  K F McFarland; E W Catalano; J F Day; S R Thorpe; J W Baynes
Journal:  Diabetes       Date:  1979-11       Impact factor: 9.461

6.  Glycoprotein metabolism in human renal disease: serum glycoproteins and glycoprotein: glycosyl transferase levels in chronic renal failure.

Authors:  B B Kirschbaum
Journal:  J Lab Clin Med       Date:  1975-11

7.  Nonenzymatic glycosylation of low density lipoproteins in vitro. Effects on cell-interactive properties.

Authors:  B Gonen; J Baenziger; G Schonfeld; D Jacobson; P Farrar
Journal:  Diabetes       Date:  1981-10       Impact factor: 9.461

8.  Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum.

Authors:  J F Day; S R Thorpe; J W Baynes
Journal:  J Biol Chem       Date:  1979-02-10       Impact factor: 5.157

9.  Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer patients.

Authors:  A M Dnistrian; M K Schwartz
Journal:  Clin Chem       Date:  1981-10       Impact factor: 8.327

Review 10.  Biosynthesis and function of gangliosides.

Authors:  P H Fishman; R O Brady
Journal:  Science       Date:  1976-11-26       Impact factor: 47.728

View more
  4 in total

1.  Pulsatile immunoreactive and bioactive luteinizing hormone secretion in adolescents with chronic renal failure. The Cooperative Study Group on Pubertal Development in Chronic Renal Failure (CSPCRF).

Authors:  F Schaefer; C Seidel; R Mitchell; K Schärer; W R Robertson
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

2.  Serum Total Sialic Acid and Highly Sensitive C-reactive Protein: Prognostic Markers for the Diabetic Nephropathy.

Authors:  Vandana Varma; Meena Varma; Amit Varma; Ravindra Kumar; Anuradha Bharosay; Savita Vyas
Journal:  J Lab Physicians       Date:  2016 Jan-Jun

3.  Highly Variable Sialylation Status of Donor-Specific Antibodies Does Not Impact Humoral Rejection Outcomes.

Authors:  Thomas Barba; Jean Harb; Stéphanie Ducreux; Alice Koenig; Virginie Mathias; Maud Rabeyrin; Eric Pouliquen; Antoine Sicard; Dimitri Chartoire; Emilie Dugast; Thierry Defrance; Emmanuel Morelon; Sophie Brouard; Valérie Dubois; Olivier Thaunat
Journal:  Front Immunol       Date:  2019-03-20       Impact factor: 7.561

4.  Elevated serum sialic acids, a potent biomarker of alloxan-induced type 1 diabetes in dogs by ethanolic extract of Anogeissus leiocarpus.

Authors:  King Akpofure Nelson Esievo; Sabina Mbafan Num-Adom; Sani Adamu; Ngozi Ejum Ogbuagu; Tagang Aluwong; Ismaila Alhaji Umar
Journal:  J Diabetes Metab Disord       Date:  2021-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.